Chronic rhinosinusitis is a common inflammatory disease of paranasal sinuses, which causes rhinorrhea, nasal congestion, and hyposmia. The genetic predisposition or the exposure to irritants can sustain the inflammatory response and the development of nasal polyposis.
Mesoblast's stem cell derived mesenchymal precursor cell treatment is moving into Phase III for Heart Failure patients, now the FDA...
Mesoblast Limited announced that the Phase III trial of its allogeneic mesenchymal stem cell product candidate MSC-100-IV (remestemcel-L) in children...
In this review, we focus on the features of BCSCs, emphasize the major factors and tumor environment that regulate the stemness of BCSCs, and discuss potential BCSC-targeting therapies.
Ceramide is emerging as one of the players of inflammation in lung diseases. However, data on its inflammatory role in Cystic Fibrosis (CF) as part of the extracellular machinery driven by lung mesenchymal stem cells (MSCs)...
Apceth GmbH has received approval to conduct a clinical cancer trial with its genetically modified, adult mesenchymal stem cells. This...
Both tissue repair and regeneration are a priority in regenerative medicine. Retinitis pigmentosa (RP), a complex retinal disease characterized by the progressive loss of impaired photoreceptors, is currently lacking effective therapies...
Aggregation of alpha-synuclein (alpha-syn) is neuropathologically and genetically linked to Parkinson's disease (PD). Since stereotypic cell-to-cell spreading of alpha-syn pathology is believed to contribute to disease progression...
CardioCell has announced data from its Phase IIa clinical trial "Safety and Efficacy of Intravenous Infusion of Ischemia-Tolerant Allogeneic Mesenchymal...
BrainStorm Cell Therapeutics Inc. a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced that the FDA will convene a meeting of the Cellular, Tissue and Gene Therapies Advisory Committee (ADCOM) to review the Biologics License Application (BLA) for NurOwn, its investigational mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS)